Objective: Type 2 diabetes arises from the interaction of physiological and lifestyle risk factors. Our objective was to develop a model for predicting the risk of T2D, which could use various amounts of background information.
Introduction
About 700 million people worldwide are estimated to have T2D by year 2025 (1) . To be able to halt this epidemic, we need to improve tools to prevent diabetes and also to predict it accurately. It is well known that the risk increases with increasing age, obesity, sedentary lifestyle, hypertension, dyslipidemia, depression and unfavorable socioeconomic factors, as well as with history of gestational diabetes and family history of diabetes (2, 3, 4, 5, 6 ) suggesting a strong genetic predisposition (7) .
As hyperglycemia is often asymptomatic, T2D can remain undetected for years and complications can appear already at the time of diagnosis (8, 9) . Systematic screening with an OGTT has revealed that even 25-50% of adult patients with T2D had been undiagnosed in various populations (10, 11, 12, 13, 14, 15) . As T2D can be prevented by lifestyle management (16, 17, 18, 19) and complications can be avoided with early intervention, it is of paramount importance to detect individuals at risk. However, large-scale screening with an OGTT is impractical and costly, which has led to the development of risk scores as first step in the identification of individuals with highest probability of either having undiagnosed diabetes or developing diabetes (20, 21) .
Our aim was to develop a model for prediction of T2D, HAPT2D in the following, which could utilize all possible information depending on data availability, similarly to the approach adopted within the Framingham study (21) . We used the 'least absolute shrinkage and selection operator' (LASSO) method (22) coupled with survival analysis in order to exploit the entire datasets and the entire time-frame of the study. In particular, we assessed whether adding a larger set of socioeconomic or environmental risk factors or factors derived from advanced modeling techniques, would improve the performance of the widely used the Finnish Diabetes Risk Score FINDRISC (20) and Framingham score (21) . For these purposes, we used a joint set of population data from the VIVA, Botnia BPS and PPP-Botnia Studies for a total of 8483 people.
Among the many predictive models available in the literature to predict T2D onset (23, 24, 25, 26, 27) , we selected the FINDRISC and the Framingham scores. The FINDRISC is one of the most widely used noninvasive risk scores (especially in Finland and Spain, from where our cohorts originated) for which a questionnaire was designed for self-screening at the population level. The Framingham score was developed, as HAPT2D, for different scenarios reflecting different degrees of available information and is among the best performers when tested on external validation cohorts (26, 27) .
Subjects and methods
Within the FP7-MOSAIC Project (MOdels and Simulation techniques for discovering diAbetes Influence faCtors) funded by the European Commission, we studied three large prospective data sets, the Botnia Prospective Study (N = 3331) and the PPP-Botnia Study (N = 3596) from Finland and the VIVA Study from Spain (N = 1556), including a total of 8483 people with no diabetes at the first visit, of whom 533 developed T2D during the follow-up (see below for details). All studies comprised a screening visit and a follow-up visit 1-22 years later (median follow-up time 8 years) with data for fasting blood samples, 75 g OGTT, anthropometric data, as well as information on co-morbidities, socioeconomic status and lifestyle. Variables common to all three datasets were identified, their coding was harmonized and the ones with overall proportion of missing data below 30% were considered for follow-up analysis (Table 1) . Missing values were imputed with the k-Nearest Neighbor algorithm, using the Heterogeneous Euclidean Overlap Metric as a measure of distance between records (28). The number of neighbors k was set to the optimal value 25 after a tuning procedure on the available data.
Diabetes was defined as plasma glucose at fasting (FPG) ≥7.0 mmol/L or 2-h PG ≥11.1 mmol/L. The metabolic syndrome (MS) was defined according to the International Diabetes Federation criteria (29) as central obesity (waist circumference ≥94 cm for men and ≥80 cm for women), plus any two of the following criteria: (1) serum triglyceride concentration ≥1.7 mmol/L, or medication for this; (2) serum HDL cholesterol concentration <1.03 in men or 1.29 mmol/L in women, or medication for this; (3) systolic blood pressure ≥130 or diastolic blood pressure ≥85 mmHg, or medication for hypertension and (4) FPG ≥5.6 mmol/L, or previously diagnosed T2D. The Homeostatic Model Assessment of insulin resistance index (HOMA_IR = FPG * FS-insulin/22.5) and betacell index (HOMA_B; (30)) were calculated. Tertiles of HOMA_B were used because of the high kurtosis of its distribution and negative values were pooled with the third tertile. Categorical variables such as profession and marital status were represented using one-hot variables; for example, the marital status was split in four variables (single, married, widowed, divorced) each taking the value 1 or 2 to indicate yes and no. A variable 'country' was added to account for differences in the Spanish and Finnish populations (Fig. 1) . (31, 32, 33) . By the end of 2013, follow-up data were available for 3331 participants with an average follow-up time of 9.1 (s.d. 4.5) years and with 215 incident T2D. The Prevalence, Prediction and Prevention of diabetes (PPP) -Botnia Study is a population-based study in the same region designed to obtain accurate estimates of prevalence and risk factors for diabetes, impaired glucose tolerance and the MS in the population aged 18-75 years (34) . A random sample of individuals was invited from the population registry, of which 5208 (54.7%) participated in the baseline study in 2004-2008 representing 6-7% of the population in the target age group (comprising 96 000 individuals). At baseline, 327 (6.3%) had diabetes, 354 (6.8%) impaired glucose tolerance and 416 (8.0%) impaired fasting glucose (33) . Of the 3850 (76.5% of those alive) people who participated in the follow-up examination in 2011-2015, data for 3596 were used in the present study (254 people were excluded due to insufficient follow-up information). Of them, 152 (4%) had developed T2D. Data for the first 2000 individuals participating in the follow-up, 97 of whom had developed T2D, were retrospectively used for building the predictive model (PPP1). The latter part of the follow-up cohort (1596 people, 55 with incident T2D), examined after the initiation of the present study, was used for the validation of the model (PPP2, validation set 2). The participants in the BPS and PPP-Botnia studies gave their written informed consent and the study protocol was approved by the Ethics Committee of Helsinki University Hospital, Finland.
All people participated in a 75 g OGTT after a 10-to 12-h fast. Samples for plasma glucose and serum insulin were drawn at −10, 0, 30, 60 and 120 min (BPS) or 0, 30 and 120 min (PPP-BOTNIA), and for total cholesterol, HDL cholesterol and triglycerides at 0 min. Body weight, height, waist and hip circumference as well as heart rate were measured. The mean value was calculated from two blood pressure recordings obtained from the right arm of a sitting person after 30 min of rest at 5-min intervals. The study participants filled in a structured questionnaire to provide information on marital status, occupation, length of education, exercise, alcohol consumption, smoking, cardiovascular and other diseases as well as family history of diabetes. Medication was recorded by a trained study nurse. Diagnosis of diabetes was based on the OGTT or a history of previously known diabetes applying WHO criteria. In uncertain cases, the diagnosis was confirmed from patient records.
Plasma glucose was measured with a hexokinase (Boehringer Mannheim, Mannheim, Germany; BPS) or a glucose dehydrogenase method (Hemocue, Angelholm, Sweden; PPP-BOTNIA). Serum insulin was measured by radioimmunoassay (RIA, Linco; Pharmacia, Uppsala, Sweden) or enzyme immunoassay (EIA; DAKO) in the first part of BPS, and then by fluoroimmunometric assay (FIA, AutoDelfia; Perkin Elmer Finland) in the latter part of BPS and the whole PPP-BOTNIA. For the analysis, the insulin concentrations obtained using the other assays were transformed to cohere with those obtained using the EIA. The correlation coefficient between RIA and EIA as well as FIA and EIA was 0.98 (P < 0.0001). Serum total cholesterol, HDL and triglyceride concentrations were measured first on a Cobas Mira analyzer (Hoffman LaRoche, Basel, Switzerland) and since January 2006 with an enzymatic method (Konelab 60i analyser; Thermo Electron Oy, Vantaa, Finland). LDL cholesterol concentrations were calculated using the Friedewald formula. 
The prediction model
For the modeling purposes, data from the BPS, the PPP1 and VIVA studies were combined to include 6887 people, of whom 478 had developed incident T2D during the follow-up. A subset (n = 486; 7%) of these data, stratified for sex, age, BMI and incident T2D, was set aside for validation purposes (validation set 1) leaving a training set of 6401 people. The models were created for three different scenarios reflecting different degrees of available information (Table 1) . Scenario 1 includes questionnaire data and basic measurements (weight, height, waist circumference, BMI), resembling information found in citizens clinical history records. Scenario 2 complements Scenario 1 with the usual information available for a clinician after a general visit including blood pressure and routine laboratory tests. Scenario 3 includes all the above-mentioned variables and 2h-PG.
First we used Bayesian Network analyses to study several indices for profiling glucose variability in type 2 diabetes (T2D) and to provide a probabilistic model of the relations between different T2D risk factors in the three datasets. A Bootstrap aggregation strategy on top of the Bayesian Network structure learning algorithm was exploited to obtain a ranked list of variables useful for the model, and an optimal number of variables.
For the model predicting T2D, we used the LASSO 'least absolute shrinkage and selection operator' regression analysis (LASSO, (22)) coupled with Cox survival model (36) to be able to use the whole set of available data in the entire time-frame of the study (2-20 years, Fig. 1) , not just the data at a certain time point. This produces a curve of patient risk across follow-up years, which facilitates the interpretation of prediction.
The training set (n = 6401) was further split in 100 training and 100 test sets and the model was trained in a Monte Carlo bootstrap resampling scheme (37, 38, 39, 40) with B = 100 external training/test splits separately for each of the three scenarios -one model was learned from each of these training sets and validated on the corresponding test set resulting in 100 different scores of the method performance. In addition, as LASSO selects a number of variables significant for prediction of T2D for each model, we obtained 100 lists of variables that can be ranked based on the number of times a variable is selected by different models allowing us to rank the variables based on their ability to predict the onset of T2D being robust to overfitting (38, 39, 40) . The training data were scaled with respect to their maximum and used to train three models, one for each scenario, using the package 'survival' in R (36) .
The final survival model was trained on the entire training set of 6401 people using the top ranking variables. The optimal number of variables was chosen as the one optimizing the average performance across the 100 test sets.
The final model performance on the three scenarios described earlier was assessed on validation sets 1 and 2. The outcome produced by each of the three predictive algorithms is twofold: (i) a predictive model of the risk of developing T2D in the future assessed in terms of Integrated Areas Under the ROC Curve (iAUCs) (41, 42) and (ii) a selection and ranking of the variables based on their ability to predict the risk of developing T2D. We also considered AUC at 6 years from the baseline visit, which corresponds to a reasonable number of cases developing diabetes in our dataset ( Fig. 1) and is in the time range of FINDRISC and Framingham predictions, thus allowing a comparison with these two traditional scores. We assessed FINDRISC and Framingham performance on the 100 internal test splits in addition to the external validation data sets 1 and 2 and got 100 performance scores for each model. Finally, the performance of the method was 
FINDRISC and Framingham score implementation
The FINDRISC score was implemented according to the paper by Lindström and Tuomilehto (20) and subsequent updates, using the following variables: sex, age, BMI, waist circumference, antihypertensive medication, information on physical activity habits and physical work and history of high blood glucose. The variable high blood glucose includes any occasional measurement of abnormal glucose in the past, could be fasting or postprandial, pre-diabetic or diabetic range. In practice, the patient has been told that he/she has an abnormal value, but no diagnosis of permanent diabetes has been made (for example, this could have been e.g. in conjunction with an infection). 
Results
The three models developed for Scenarios 1, 2 and 3 predicted T2D risk during the whole follow-up time with iAUC (SD) on the test set by 0.83 (0.03), 0.87 (0.02) and 0.90 (0.02), respectively (boxplots in Fig. 2, left panel) . This performance was corroborated in the validation data sets 1 and 2, in which all scenarios showed performance higher or equal to an iAUC of 0.85 (Scenarios 1, 2, 3; validation set 1: 0.85, 0.85, 0.95; validation set 2: 0.87, 0.91, 0.91, respectively). The average performance obtained including 2-h-PG (Scenario 3) outperformed those obtained in the other scenarios (P < 10 −15 for Scenario 3 vs either Scenario
or Scenario 1, t-test).
AUCs at year 6 obtained with Scenarios 1, 2 and 3 ( Fig. 2, right panel) were consistent with iAUCs for the whole follow-up time (Fig. 2, right panel) on both validation sets 1 (0.87, 0.89 and 0.95, respectively) and 2 (0.90, 0.98, 0.96, respectively). When testing the FINDRISC score, AUC at year 6 was lower than using HAPT2D for both validation sets 1 and 2 (AUC equal to 0.80 and 0.88, respectively). Moreover, on the test sets, HAPT2D performed better than FINDRISC on all the three scenarios (Fig. 2 , right panel, P < 10 −10 ).
Also, compared with the Framingham score, HAPT2D performed better on validation set 1 (AUC = 0.71) and on the test sets (P < 10 −15 for all the three scenarios), but the performance of Framingham score was similar to those obtained in Scenario 1 using validation set 2 (AUC = 0.9). The variables selected and ranked for their ability to predict T2D are shown in Table 2 . The lower the rank, the more frequently the variable was selected as a good www.eje-online.org predictor using different data subsamples. 2-h PG and FPG were among the best predictors in the scenarios together with other known predictors of T2D, i.e. waist circumference, age, sex, family history of diabetes and blood pressure (Table 2 ). In addition, smoking habits, marital and occupational status got selected in the prediction models, as well as the variable country (Table 2) , which accounts for a higher risk of Finnish population with respect to Spanish ( Fig. 1 and Supplementary data, see section on Supplementary data given at the end of this article).
In the most informative scenarios, we included some variables that are highly related to each other such as history of high glucose (positive answer from a patient to a questionnaire) and FPG levels or waist circumference, triglycerides and MS. However, the feature selection step automatically selects the most informative variables, ranking them and discarding those that do not add any further advantage to the model performance. For example, as shown in Table 2 , FBG is selected in Scenarios 2 and 3, whereas 'history of high glucose' is selected only in Scenario 1, where FBG is not available. On the opposite, in Scenario 2, waist circumference, triglycerides and MS are all selected, although this latter with a low rank, indicating that MS helps improving the prediction possibly because it introduce further information on HDL and blood pressure status.
The model equations and parameters are available in Supplementary data and its implementation is available at http://sysbiobig.dei.unipd.it/?q=Software" \l "HAPT2D" \t "_blank).
Discussion
The three models predicted T2D risk with an average integrated area under the ROC curve equal to 0.83, 0.87 and 0.90, respectively. The average performance obtained including 2-h PG (Scenario 3) outperformed those obtained in the other scenarios, and the Scenario 2 outperformed Scenario 1, the difference being more clear between the first and second scenarios compared to the difference between the second and the third scenarios. The first scenario included variables available without blood samples. For the Scenario 2, fasting blood sample with glucose, insulin and lipids is needed, as well as measurement of pulse and blood pressure. For Scenario 3, OGTT is needed. The performance at six years (AUC 0.87-0.95) overcame that of the state-of-the-art FINDRISC and Framingham risk scores (AUC 0.80 and 0.75, respectively). Even the simplest model using only noninvasive data was a good predictor, and the model with the richest data predicted incident diabetes better than 1-h plasma glucose previously shown to be highly predictive in the BPS (43) .
Several risk scores for predicting T2D have been developed utilizing various amounts of background and laboratory data (27) . Many factors affect their performance, including the richness of data, handling of missing data, generalizability to other populations and whether individual or population risk is targeted. To construct HAPT2D, we adopted the approach outlined in the Framingham study (20) and assessed the ability of the model to predict the onset of T2D with different degrees of available information. As hypothesized, but differing Table 2 Variables selected (recursive feature elimination) in different scenarios and their average ranking based on ability to predict the risk of developing T2D. The average rank of the variable across the 100 bootstrap samples from the training set is shown. The lower the rank, the more frequently the variable was selected as a good predictor using different data subsamples. 
www.eje-online.org from the Framingham score, feeding the model with more data progressively improved the performance in terms of iAUC, and this was even more apparent as regards AUC at 6 years. The variables that predicted best the risk of T2D included: country, waist circumference, family history of diabetes, fasting glucose, heart rate, diastolic blood pressure and 2-h glucose at OGTT. In addition, although with lower rank, variables related to smoking habits, as well as marital and professional status, together with HOMA_B, waist circumference, blood pressure, triglycerides, age and sex, were selected as predictive ( Table 2 ). These are mainly known risk factors for T2D and were expected. Country of origin covers differences in the Spanish and Finnish populations, including lifestyle habits, study design and genetic background, a known risk factor for T2D (32) . This highlights the importance of recalibrating the predictive models when using them on different populations (44) .
Also heart rate, somewhat surprisingly, got included as a predictive variable -although contrary to the expected direction, low heart rate was not protective in the model. The use of beta blockers might explain the finding, but as all antihypertensive medications were pooled in the same variable, this could not be assessed. It is also possible, that the finding is a true association, as reduced heart rate variability has been shown to associate with insulin resistance and lower insulin sensitivity, and decreased insulin sensitivity index has been linked with parasympathetic dysfunction, primarily in nonoverweight individuals (45) .
The variable physical work was included in all three scenarios as a detrimental factor increasing the risk of developing T2D. If we think of physical work as a proxy of physical activity, this is somehow surprising. We think that in this model, such as in other models including environmental variables, some variables might be a proxy of a number of different variables which are maybe not directly measured, but that are predictive. For example, in our case physical work might be a proxy of a low socioeconomic status.
Unlike the previous modeling approaches, we adapted 'least absolute shrinkage and selection operator' (LASSO) method for creating the predictive models. This method enables us to tackle the low incidence of diabetes (7%) and varying follow-up time (Fig. 1) in our data. The low incidence of T2D in our data may have led to results by chance only, but on the other hand, the results were consistent. One benefit of LASSO is its output, a curve of patient risk over the years, which makes the interpretation of the result easier and usable also at daily clinical practice.
For an individual, a visualized risk of T2D might be an incentive for lifestyle changes and a clinician might be more alert as regards T2D risk.
For clinical use, it might be of interest to fix a threshold of risk. Such a threshold can be chosen based on a compromise between false positives and false negative cases on the available data. For example, in the model implementation available at http://147.162.226.104:8000/ (temporary link accessible to the reviewers with Username: HAPT2D and password dicamilloetal) the prediction is shown as the cumulative risk of developing T2D in the course of 12 years (Fig. 3) .
There are a few other previously developed scores for prediction of T2D. In some of them, Cambridge, DPoRT, FINDRISC and T2D diagnosis were based on registry data or was self-reported and some used fasting glucose measurement (ARIC, DESIR) instead of OGTT (27) . The Figure 3 Exemplifying curve of patient risk over the years. Each point on the black line corresponds to the probability of developing T2D within the number of years shown on the x axis. As a guideline to determine how high the shown risk level actually is, compared to the observed prognoses in the training population, four color-coded bands are shown. The area in dark gray represents high risk (50% of the subjects with a risk curve in this area eventually developed diabetes within 12 years); the area in mid gray represents medium-high risk (25% of the subjects with a risk curve in this area eventually developed diabetes within 12 years); the light gray represents a medium risk (10% of the subjects with a risk curve in this area eventually developed diabetes within 12 years); the white area represents a low risk (less than 10% of the subjects with a risk curve in this area eventually developed diabetes within 12 years). strength of our study is the reliable diagnosis of T2D based on OGTT and careful examination of the patient records. The methods in our population studies were also well defined.
When comparing the results with Framingham and FINDRISC models, we found that feeding only nonlaboratory data (Scenario 1), HAPT2D performed better in the prediction of T2D than the FINDRISC score utilizing a smaller selection of non-laboratory data and the Framingham risk score, which also includes data on blood pressure measurements, fasting glucose, insulin and lipids.
The improvement in prediction is probably due to several reasons. Firstly, with LASSO coupled with survival analysis, we could take advantage of the entire follow-up regardless of its length and censored data, while FINDRISC (20) , Framingham (21) and other approaches (46) used a fixed time horizon between the visits. Full exploitation of the available data results in a more robust model identification procedure. In fact, when we trained different prediction models such as Support Vector Machines and LASSO not coupled with survival analysis, we obtained performance similar to those obtained by Framingham (data not shown). Secondly, the bootstrap approach we used to obtain an average estimate of the models accuracy and to select the predicting variables has previously been shown able to predict the average performance on the internal test splits in a way that resembles closely the actual performance on an external, previously unseen, validation set (37, 39) . Third, we were able to include a large number of variables in HAPT2D: traditionally used risk factors, socioeconomic and environmental factors, biochemical data as well as OGTT-derived data like the HOMA_IR and HOMA_B indices. Similar difference in performance between the models and the FINDRISC and Framingham scores was observed on the first but not the second validation set, where the Framingham score performed as well as the Scenario 1 model (AUC = 0.9). Also Framingham score utilizes a wide variety of data that may explain this finding. However, Framingham AUC showed high variability on different datasets, ranging from to 0.61 to 0.84 on different bootstrap samples. Furthermore, the performance of different models has been shown to vary with country, age, sex and adiposity, and discrimination can vary across BMI and waist circumference strata (27) , but there were no obvious differences in these variables between the training and the validation datasets. In the validation study of Kengne et al. (27) comparing different prediction tools, FINDRISC acceptably predicted the overall rate of incident diabetes in age subgroups, but the discrimination of Framingham model was better.
As an external validation data, we used the latter part of the Botnia-PPP study (PPP2). It can be argued that this validation was not totally independent of the data, the model construction was based on (PPP1). However, firstly, the original study population was randomly selected from the population registry, and secondly, the diabetes status of the PPP2 individuals was unknown at the time the models were constructed. Thirdly, the order of the follow-up examination was not related to the diabetes status in any way.
It can be debated whether there is a real need for one more T2D risk calculator. However, the world and the clinical practice are changing rapidly to be more computerized and personalized. While previously, counting a risk for T2D was more or less cumbersome even with a help of manual risk calculation aids, in the future, data mining techniques enable an automatic risk calculation in seconds. Also, an easy to visualize output, such as ours, would certainly benefit clinicians and patients at risk. It is also clear that there are differences across populations regarding the risk of T2D. With the current worldwide T2D epidemic, it is only an advantage to have one more risk calculator at hand.
